Insiders, Startups, Venture Capital

Where the money is: Top 100 VCs investing in US biotechs during 2017

It was a big year for US biotechs raising cash from VCs, with flush investors sinking a record-breaking $10.5 billion into new and growing companies during 2017. Who’s deploying the dollars, and where's the money coming from? We put together a fresh list of the top 100 VC firms investing in US biotechs, and the data might surprise you.

We did this list in 2016 looking at 2015 data, and it was one of our most popular reports of the year. We checked back in, and what we found looked quite different than our 2015 report.

While there’s a lot of repeat players, we’re also seeing an interesting shift in where big money is coming from. Back in 2015, four of the top five VCs were based in Boston/Cambridge. This year, three out of the top five VCs were based in the San Francisco Bay Area. Only one was from Massachusetts.

Endpoints Insider

Endpoints Enterprise

Unlock this article along with other benefits by subscribing to one of our paid plans.
Already a subscriber? Log in now
← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 34,900+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 34,900+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biotech Investment Analyst
SV Health Investors Boston, MA
Research Scientist - Disease Biology
Recursion Pharmaceuticals Salt Lake City, UT
Senior Scientist - Predictive Pharmacology
Recursion Pharmaceuticals Salt Lake City, UT
Director, Translational Sciences
Cadent Therapeutics Cambridge, MA
Director of Marketing
twoXAR Mountain View, CA

Visit Endpoints Careers ->